West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 804,600 | 766,500 | 698,000 | 748,800 | 746,900 |
| Cost of Goods | 510,300 | 492,600 | 466,100 | 475,200 | 482,200 |
| Gross Profit | 294,300 | 273,900 | 231,900 | 273,600 | 264,700 |
| Operating Expenses | 127,000 | 120,800 | 125,000 | 114,200 | 103,600 |
| Operating Income | 167,600 | 153,700 | 107,000 | 159,600 | 161,300 |
| Interest Expense | 200 | 100 | 400 | -800 | 700 |
| Other Income | 6,600 | 8,400 | 7,300 | 6,500 | 7,800 |
| Pre-tax Income | 174,000 | 162,000 | 113,900 | 166,900 | 168,400 |
| Income Tax | 34,000 | 30,200 | 24,100 | 36,800 | 32,400 |
| Net Income Continuous | 140,000 | 131,800 | 89,800 | 130,100 | 136,000 |
| Net Income | $140,000 | $131,800 | $89,800 | $130,100 | $136,000 |
| EPS Basic Total Ops | 1.94 | 1.82 | 1.24 | 1.79 | 1.87 |
| EPS Basic Continuous Ops | 1.94 | 1.83 | 1.24 | 1.79 | 1.87 |
| EPS Diluted Total Ops | 1.92 | 1.82 | 1.23 | 1.78 | 1.85 |
| EPS Diluted Continuous Ops | 1.93 | 1.82 | 1.23 | 1.77 | 1.85 |
| EPS Diluted Before Non-Recurring Items | 1.96 | 1.84 | 1.45 | 1.82 | 1.85 |
| EBITDA(a) | $210,600 | $195,100 | $147,000 | $200,300 | $201,500 |